A targeted genetic testing for idiopathic ventricular fibrillation revealed a mutation in the desmoglein-2 (DSG2) gene involved in arrhythmogenic right ventricular cardiomyopathy (ARVC). The gene discussed is DSG2; the disease is arrhythmogenic right ventricular cardiomyopathy.